News

Sort by:

The “2023 Anbogen Medical Student Forum” was held on February 24th

AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101

September, 2022

The ABT101-102 clinical trial was approved by the Ministry of Health and Welfare and will be conducted at multiple medical centers.